Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Comirnaty Bivalent Vaccine Arrives in Hong Kong SAR and Macau SAR and Will Soon Be Available to the Local Residents 2022-11-28 22:59
Fosun Pharma's MSCI ESG Rating Upgraded to A 2022-10-14 08:26
Fosun Pharma and MAIA Pharmaceuticals Jointly Announce the Successful Commercialization of Only FDA Approved 20ml Sodium Phenylacetate and Sodium Benzoate (SPSB) Liquid Product 2022-09-26 22:13
Fosun Pharma Announces 2022 Interim Results 2022-08-30 20:28
World Malaria Day: Fosun Pharma's Self-Developed Artemisinin Series Become Symbol of China's Innovative Medicines 2022-04-25 17:00
Fosun Diagnostics Receives China NMPA Approval for Its Independently Developed Novel Coronavirus Antigen Detection Kit Amidst of The National Efforts in Pandemic Prevention and Control 2022-04-14 19:45
Fosun Pharma 2021 Annual Results Announcement: Accelerating the Globalization Comprehensively 2022-03-23 06:53
Fosun Pharma and Insilico Medicine Announce a Strategic, AI-driven Drug Discovery and Development Collaboration to Jointly Advance Multiple Targets 2022-01-11 16:30
Fosun Pharma Announces 2020 Annual Results 2021-03-30 00:38
BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong for COVID-19 Vaccine 2021-01-26 01:18
Fosun Pharma Announces 2020 Interim Results 2020-08-26 22:03
Fosun Pharma Announces its Licensed COVID-19 Vaccine Product Receives Acceptance Notice of Clinical Trial Application by NMPA 2020-07-14 20:00
Fosun Pharma Invites Chinese and Foreign Experts to Jointly Discuss Prevention and Control Measures of COVID-19 Epidemic in Africa 2020-04-30 00:50
Fosun Pharma Receives FDA Emergency Use Authorization (EUA) For Its COVID-19 RT-PCR Detection Kit 2020-04-19 20:00
Fosun Pharma Announces 2019 Annual Results 2020-03-31 17:51
Fosun Pharma's Novel Coronavirus Nucleic Acid Detection Kit Receives Emergency Approval from China NMPA 2020-03-26 22:27
Fosun Pharma, HOPU Investments, CEL Healthcare Fund, and WuXi PharmaTech to Jointly Acquire U.S. Innovative Biotechnology Company Ambrx 2015-05-22 07:00
Fosun Pharma Listed in CCTV Financial 50 Index Sample Stock 2013-08-13 21:30
Fosun Pharma Awarded "China's Most Innovative Pharmaceutical Enterprise" 2013-06-25 20:31
1 2